MicroPort Orthopedics Optimizing its Episode of Care for Surgeons and Patients, Investing In New Technologies and Partnerships

MicroPort Orthopedics, a global leader in orthopedic devices and technologies, is taking an Episode of Care approach to enhance operational efficiency and patient satisfaction throughout the 90 days both before and after surgery.

MicroPort is investing in new strategic technologies and partnerships with the vision to improve efficiencies, patient outcomes, and provider productivity.
Technologies built specifically around streamlining the Episode of Care ensure patients are prepared mentally and physically for their procedure and have digital resources to communicate with their doctors throughout the recovery process. Additionally, the resources can help healthcare providers monitor patients, predict risk, and manage outcomes.
To increase patient engagement and systematically measure patient outcomes, MicroPort recently partnered with PatientIQ, a platform that combines industry-leading patient engagement technology with research quality advanced analytics.
Together, PatientIQ and MicroPort Orthopedics are guiding the future of orthopedic care. With over 1,600 online education modules, PatientIQ provides a top-tier patient experience that can be specifically tailored to a procedure or a diagnosis. In addition to preoperatively educating and optimizing patients for their upcoming surgery, the platform also administers patient outcomes surveys and automates data collection throughout the entire Episode of Care to provide full service and support to both patients and surgeons.
MicroPort Orthopedics has also recently partnered with Dr. Aaron Salyapongse, orthopaedic surgeon in Dublin, California, to develop a Virtual Joint Class series moving patient education content to a digital format, allowing them to prepare for their upcoming surgery.
These classes, available through MicroPort’s proprietary PATHWAYS program, are specifically designed in a relatable and interactive blackboard style format to keep patients interested and engaged. They provide details about what to expect during and after the procedure. The classes not only introduce a breadth of topics including surgical preparation, anesthesia, discharge criteria, and post-op pain management, but also preemptively address many of the common causes for patient adverse events and readmissions.”
“Over the last 20 years, total joint replacement surgery has undergone a significant evolution. In the early 2000s, it was common for patients to spend days in a hospital for a procedure and then be moved to a skilled nursing facility for several weeks. Today, patients are routinely discharged hours after the procedure without any added risk and at a lower cost compared to a traditional inpatient setting,” said Benny Hagag, president of MicroPort Orthopedics.
Hagag concluded, “These systemic changes to the Episode of Care, combined with the impact of COVID-19 on today’s healthcare system, have required companies to adapt and prioritize innovation and technology at the center of care. Our recent collaboration and strategic partnerships with like-minded companies and surgeons are what keep us advancing toward positive patient outcomes and effective procedures, and we are only getting started.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”